Kang et al., 2020 - Google Patents
Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatmentKang et al., 2020
View PDF- Document ID
- 16308360926662002975
- Author
- Kang S
- Peng W
- Zhu Y
- Lu S
- Zhou M
- Lin W
- Wu W
- Huang S
- Jiang L
- Luo X
- Deng M
- Publication year
- Publication venue
- International journal of antimicrobial agents
External Links
Snippet
Viral respiratory diseases such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) always pose a severe threat to people. First identified in late December 2019, a novel coronavirus (2019-nCoV; SARS-CoV-2) has affected many …
- 241001678559 COVID-19 virus 0 title abstract description 90
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kang et al. | Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment | |
| Da Silva et al. | Two years into the COVID-19 pandemic: lessons learned | |
| Kumar et al. | Wuhan to world: the COVID-19 pandemic | |
| Al-Qahtani | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): emergence, history, basic and clinical aspects | |
| Attia et al. | COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review | |
| Beig Parikhani et al. | The inclusive review on SARS-CoV-2 biology, epidemiology, diagnosis, and potential management options | |
| Tizaoui et al. | Update of the current knowledge on genetics, evolution, immunopathogenesis, and transmission for coronavirus disease 19 (COVID-19) | |
| Luo et al. | Combating the coronavirus pandemic: early detection, medical treatment, and a concerted effort by the global community | |
| Aghamirza Moghim Aliabadi et al. | COVID‐19: A systematic review and update on prevention, diagnosis, and treatment | |
| Soufi et al. | SARS-CoV-2 (COVID-19): new discoveries and current challenges | |
| Zehra et al. | Corona virus versus existence of human on the earth: A computational and biophysical approach | |
| Khan et al. | Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective | |
| Bahrami et al. | Genetic and pathogenic characterization of SARS-CoV-2: a review | |
| Santos-Sánchez et al. | Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19 | |
| Shang et al. | Recent insights into emerging coronavirus: SARS-CoV-2 | |
| Balachandar et al. | COVID-19: A promising cure for the global panic | |
| Grudlewska-Buda et al. | Sars-cov-2—morphology, transmission and diagnosis during pandemic, review with element of meta-analysis | |
| Parlakpinar et al. | SARS‐COV‐2 (COVID‐19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments | |
| Li et al. | SARS-CoV-2 virology | |
| MAJUMDER et al. | Aj csian ournalof hemistry aj csian ournalof hemistry | |
| Ekrami et al. | Potential diagnostic systems for coronavirus detection: a critical review | |
| Aziz et al. | COVID-19 impacts, diagnosis and possible therapeutic techniques: a comprehensive review | |
| Devasena | Nanotechnology-COVID-19 interface | |
| Kaur et al. | The omic insights on unfolding saga of COVID-19 | |
| Miatmoko et al. | The Use of Azithromycin and Lopinavir-Ritonavir in the Treatment of COVID-19 |